Telmisartan is an angiotensin-converting enzyme inhibitor (ACEI) that is used alone or in combination with other drugs to treat hypertension, cardiac arrest, and stroke.
In 1998, telmisartan was licensed in the United States for the treatment of hypertension.
Telmisartan is a generic and trade name for telmisartan, which comes in doses of 20, 40, and 80 mg.
In adults, a common dose of Telmisartan market is 40 to 80 mg once daily, and it is used for a long time.
Telmisartan is also available in fixed combinations with amlodipine and hydrochlorothiazide.
Market Trends
The global prevalence of high blood pressure is rising, owing to an aging population, chronic diseases such as diabetes, and changing lifestyles, all of which are likely to boost demand for telmisartan in the global market.
Read More @ https://cmiinfopiece.blogspot.com/2021/11/global-telmisartan-market-market-trends.html
